81212 Brca1&2 185&5385&6174 vrnt
Pathology & Lab
Also known as: BRCA1/2 Ashkenazi mutation panel, BRCA Jewish founder testing
Targeted mutation analysis of BRCA1 and BRCA2 genes to detect specific founder mutations (185delAG, 5385insC, 6174delT) common in Ashkenazi Jewish populations.
Clinical Context
Used as screening test in individuals of Ashkenazi Jewish descent to identify high-risk BRCA mutations with higher prevalence in this population.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.